Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2021 Filed Dec 2, 2021 02:17 UTC |
GIBSON JOHN W JRDirector · CEO and President
|
PurchaseCommon Shares | 2,000 | $0.78 | $1,560.00 |
DisclosureSEC source: 0000928054-21-000169 · wf-form4_163841144367607.xml · nonDerivative · entry 1 GIBSON JOHN W JR · CIK 0001189981 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 874,593 Read SEC document |
| November 25, 2021 Filed Nov 29, 2021 22:23 UTC |
Ezell Ryan GillisPresident, Chem. Technologies
|
Tax withholdingCommon Shares | 1,015 | $0.82 | $832.30 |
DisclosureSEC source: 0000928054-21-000167 · wf-form4_163822461884631.xml · nonDerivative · entry 1 Ezell Ryan Gillis · CIK 0001805598 · President, Chem. Technologies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,962 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:20 UTC |
GIBSON JOHN W JRDirector · CEO and President
|
PurchaseCommon Shares | 2,000 | $1.23 | $2,460.00 |
DisclosureSEC source: 0000928054-21-000154 · wf-form4_163588438389539.xml · nonDerivative · entry 1 GIBSON JOHN W JR · CIK 0001189981 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 872,593 Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 23:22 UTC |
Ezell Ryan GillisPresident, Chem. Technologies
|
Tax withholdingCommon Shares | 1,624 | $1.26 | $2,046.24 |
DisclosureSEC source: 0000928054-21-000146 · wf-form4_163338973920604.xml · nonDerivative · entry 1 Ezell Ryan Gillis · CIK 0001805598 · President, Chem. Technologies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,977 Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 23:24 UTC |
GIBSON JOHN W JRDirector · CEO and President
|
PurchaseCommon Shares | 2,000 | $1.22 | $2,440.00 |
DisclosureSEC source: 0000928054-21-000148 · wf-form4_163338986823066.xml · nonDerivative · entry 1 GIBSON JOHN W JR · CIK 0001189981 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 870,593 Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 23:53 UTC |
Silas James ASVP Research and Innovation
|
Tax withholdingCommon Stock | 4,263 | $1.30 | $5,541.90 |
DisclosureSEC source: 0000928054-21-000144 · wf-form4_163123161099978.xml · nonDerivative · entry 1 Silas James A · CIK 0001771630 · SVP Research and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,072 Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 23:51 UTC |
Koid TengBengPresident Global Business
|
Tax withholdingCommon Shares | 4,108 | $1.30 | $5,340.40 |
DisclosureSEC source: 0000928054-21-000142 · wf-form4_163123149637389.xml · nonDerivative · entry 1 Koid TengBeng · CIK 0001413765 · President Global Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,971 Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 23:49 UTC |
Ezell Ryan GillisPresident, Chem. Technologies
|
Tax withholdingCommon Shares | 4,984 | $1.30 | $6,479.20 |
DisclosureSEC source: 0000928054-21-000140 · wf-form4_163123138119727.xml · nonDerivative · entry 1 Ezell Ryan Gillis · CIK 0001805598 · President, Chem. Technologies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,601 Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 23:48 UTC |
Borton Michael E.Chief Financial Officer
|
Tax withholdingCommon Shares | 2,640 | $1.30 | $3,432.00 |
DisclosureSEC source: 0000928054-21-000138 · wf-form4_163123127749588.xml · nonDerivative · entry 1 Borton Michael E. · CIK 0001817633 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,610 Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 23:46 UTC |
Bigney Nicholas J.SVP General Counsel
|
Tax withholdingCommon Stock | 3,839 | $1.30 | $4,990.70 |
DisclosureSEC source: 0000928054-21-000136 · wf-form4_163123116614652.xml · nonDerivative · entry 1 Bigney Nicholas J. · CIK 0001801480 · SVP General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,099 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:59 UTC |
GIBSON JOHN W JRDirector · CEO and President
|
PurchaseCommon Shares | 2,000 | $1.37 | $2,740.00 |
DisclosureSEC source: 0000928054-21-000134 · wf-form4_163061993901830.xml · nonDerivative · entry 1 GIBSON JOHN W JR · CIK 0001189981 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 868,593 Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:43 UTC |
Borton Michael E.Chief Financial Officer
|
Tax withholdingCommon Shares | 19,480 | $1.70 | $33,116.00 |
DisclosureSEC source: 0000928054-21-000126 · wf-form4_162819619858471.xml · nonDerivative · entry 1 Borton Michael E. · CIK 0001817633 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,250 Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 22:23 UTC |
GIBSON JOHN W JRDirector · CEO and President
|
PurchaseCommon Shares | 2,000 | $1.71 | $3,420.00 |
DisclosureSEC source: 0000928054-21-000124 · wf-form4_162802938679010.xml · nonDerivative · entry 1 GIBSON JOHN W JR · CIK 0001189981 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 866,593 Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 01:14 UTC |
Koid TengBengPresident Global Business
|
Tax withholdingCommon Shares | 16,234 | $1.73 | $28,084.82 |
DisclosureSEC source: 0000928054-21-000122 · wf-form4_162518845465646.xml · nonDerivative · entry 1 Koid TengBeng · CIK 0001413765 · President Global Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,079 Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 01:13 UTC |
GIBSON JOHN W JRDirector · CEO and President
|
PurchaseCommon Shares | 2,000 | $1.80 | $3,600.00 |
DisclosureSEC source: 0000928054-21-000121 · wf-form4_162518838571087.xml · nonDerivative · entry 1 GIBSON JOHN W JR · CIK 0001189981 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 864,593 Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 22:48 UTC |
Fucci MichaelDirector
|
GrantCommon Shares | 47,170 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000105 · wf-form4_162310611262606.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,663 F1 · shares: Grant of shares for annual retainer. Shares vest at the earlier of one year from date of grant and the 2022 annual meeting. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 22:54 UTC |
Nierenberg DavidDirector
|
GrantCommon Stock | 103,774 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000111 · wf-form4_162310644250968.xml · nonDerivative · entry 1 Nierenberg David · CIK 0001040899 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,111 F1 · shares: Grant of shares for annual retainer and board fees, which Mr. Nierenberg elected to take in stock rather than cash. Shares vest at the earlier of one year from date of grant and the 2022 annual meeting. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 22:52 UTC |
Mayr LisaDirector
|
GrantCommon Shares | 47,170 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000109 · wf-form4_162310632610739.xml · nonDerivative · entry 1 Mayr Lisa · CIK 0001793283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,170 F1 · shares: Grant of shares for annual retainer. Shares vest at the earlier of one year from date of grant and the 2022 annual meeting. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 22:50 UTC |
HOBBY PAUL WDirector
|
GrantCommon Stock | 86,792 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000107 · wf-form4_162310622462661.xml · nonDerivative · entry 1 HOBBY PAUL W · CIK 0001092063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,747 F1 · shares: Grant of shares for annual retainer and board fees, which Mr. Hobby elected to take in stock rather than cash. Shares vest at the earlier of one year from date of grant and the 2022 annual meeting. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 22:47 UTC |
Brown Ted DDirector
|
GrantCommon Stock | 77,358 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000103 · wf-form4_162310600941488.xml · nonDerivative · entry 1 Brown Ted D · CIK 0001297978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,790 F1 · shares: Grant of shares for annual retainer and board fees, which Mr. Brown elected to take in stock rather than cash. Shares vest at the earlier of one year from date of grant and the 2022 annual meeting. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 22:45 UTC |
Agadi Harshavardhan VDirector
|
GrantCommon Shares | 88,679 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000101 · wf-form4_162310590443671.xml · nonDerivative · entry 1 Agadi Harshavardhan V · CIK 0001498132 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,679 F1 · shares: Grant of shares for annual retainer and board fees, which Mr. Agadi elected to take in stock rather than cash. Shares vest at the earlier of one year from date of grant and the 2022 annual meeting. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:07 UTC |
Ezell Ryan GillisPresident, Chem. Technologies
|
GrantStock Option · Derivative | 145,834 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000079 · wf-form4_161905360659621.xml · derivative · entry 3 Ezell Ryan Gillis · CIK 0001805598 · President, Chem. Technologies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,668 Underlying: Common Shares · 145,834 shares Expires 2031-04-19 F3 · derivative.exercise_date: Restricted options to purchase common stock. Options vest based on percentage of revenue from new products developed over a three-year period. Vesting is ratable at revenue percentages of 15%, 20% and 25%, and is determined on 12/31/24. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:07 UTC |
Ezell Ryan GillisPresident, Chem. Technologies
|
GrantStock Option · Derivative | 145,834 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000079 · wf-form4_161905360659621.xml · derivative · entry 2 Ezell Ryan Gillis · CIK 0001805598 · President, Chem. Technologies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,834 Underlying: Common Shares · 145,834 shares Expires 2031-04-19 F2 · derivative.exercise_date: Restricted options to purchase common stock. Options vest ratably at share prices of $3, $4, $5 and $7. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:07 UTC |
Ezell Ryan GillisPresident, Chem. Technologies
|
GrantCommon Shares | 194,444 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000079 · wf-form4_161905360659621.xml · nonDerivative · entry 1 Ezell Ryan Gillis · CIK 0001805598 · President, Chem. Technologies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,821 F1 · shares: Restricted shares that vest ratably over four years from date of grant. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:06 UTC |
Bigney Nicholas J.SVP General Counsel
|
GrantStock Option · Derivative | 84,375 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000078 · wf-form4_161905355371243.xml · derivative · entry 3 Bigney Nicholas J. · CIK 0001801480 · SVP General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,750 Underlying: Common Stock · 84,375 shares Expires 2031-04-19 F3 · derivative.exercise_date: Restricted options to purchase common stock. Options vest based on percentage of revenue from new products developed over a three-year period. Vesting is ratable at revenue percentages of 15%, 20% and 25%, and is determined on 12/31/24. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:06 UTC |
Bigney Nicholas J.SVP General Counsel
|
GrantStock Option · Derivative | 84,375 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000078 · wf-form4_161905355371243.xml · derivative · entry 2 Bigney Nicholas J. · CIK 0001801480 · SVP General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,375 Underlying: Common Stock · 84,375 shares Expires 2031-04-19 F2 · derivative.exercise_date: Restricted options to purchase common stock. Options vest ratably at share prices of $3, $4, $5 and $7. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:06 UTC |
Bigney Nicholas J.SVP General Counsel
|
GrantCommon Stock | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000078 · wf-form4_161905355371243.xml · nonDerivative · entry 1 Bigney Nicholas J. · CIK 0001801480 · SVP General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,394 F1 · shares: Restricted shares that vest ratably over four years from date of grant. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:05 UTC |
Koid TengBengPresident Global Business
|
GrantStock Option · Derivative | 47,917 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000077 · wf-form4_161905349717449.xml · derivative · entry 4 Koid TengBeng · CIK 0001413765 · President Global Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,585 Underlying: Common Shares · 47,917 shares Expires 2031-04-19 F4 · derivative.exercise_date: Restricted options to purchase common stock. 50% of options vest ratably at share prices of $2, $5, $7, and 50% vest based on performance against 2020 peers. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:05 UTC |
Koid TengBengPresident Global Business
|
GrantStock Option · Derivative | 145,834 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000077 · wf-form4_161905349717449.xml · derivative · entry 3 Koid TengBeng · CIK 0001413765 · President Global Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,668 Underlying: Common Shares · 145,834 shares Expires 2031-04-19 F3 · derivative.exercise_date: Restricted options to purchase common stock. Options vest based on percentage of revenue from new products developed over a three-year period. Vesting is ratable at revenue percentages of 15%, 20% and 25%, and is determined on 12/31/24. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:05 UTC |
Koid TengBengPresident Global Business
|
GrantStock Option · Derivative | 145,834 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000077 · wf-form4_161905349717449.xml · derivative · entry 2 Koid TengBeng · CIK 0001413765 · President Global Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,834 Underlying: Common Shares · 145,834 shares Expires 2031-04-19 F2 · derivative.exercise_date: Restricted options to purchase common stock. Options vest ratably at share prices of $3, $4, $5 and $7. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:05 UTC |
Koid TengBengPresident Global Business
|
GrantCommon Shares | 194,444 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000077 · wf-form4_161905349717449.xml · nonDerivative · entry 1 Koid TengBeng · CIK 0001413765 · President Global Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,313 F1 · shares: Restricted shares that vest ratably over four years from date of grant. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:04 UTC |
Borton Michael E.Chief Financial Officer
|
GrantStock Option · Derivative | 141,667 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000076 · wf-form4_161905344441687.xml · derivative · entry 3 Borton Michael E. · CIK 0001817633 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,334 Underlying: Common Shares · 141,667 shares Expires 2031-04-19 F3 · derivative.exercise_date: Restricted options to purchase common stock. Options vest based on percentage of revenue from new products developed over a three-year period. Vesting is ratable at revenue percentages of 15%, 20% and 25%, and is determined on 12/31/24. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:04 UTC |
Borton Michael E.Chief Financial Officer
|
GrantStock Option · Derivative | 141,667 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000076 · wf-form4_161905344441687.xml · derivative · entry 2 Borton Michael E. · CIK 0001817633 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,667 Underlying: Common Shares · 141,667 shares Expires 2031-04-19 F2 · derivative.exercise_date: Restricted options to purchase common stock. Options vest ratably at share prices of $3, $4, $5 and $7. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:04 UTC |
Borton Michael E.Chief Financial Officer
|
GrantCommon Shares | 188,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000076 · wf-form4_161905344441687.xml · nonDerivative · entry 1 Borton Michael E. · CIK 0001817633 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,730 F1 · shares: Restricted shares that vest ratably over four years from date of grant. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:03 UTC |
Silas James ASVP Research and Innovation
|
GrantStock Option · Derivative | 89,063 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000075 · wf-form4_161905338659502.xml · derivative · entry 3 Silas James A · CIK 0001771630 · SVP Research and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,126 Underlying: Common Stock · 89,063 shares Expires 2031-04-19 F3 · derivative.exercise_date: Restricted options to purchase common stock. Options vest based on percentage of revenue from new products developed over a three-year period. Vesting is ratable at revenue percentages of 15%, 20% and 25%, and is determined on 12/31/24. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:03 UTC |
Silas James ASVP Research and Innovation
|
GrantStock Option · Derivative | 89,063 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000075 · wf-form4_161905338659502.xml · derivative · entry 2 Silas James A · CIK 0001771630 · SVP Research and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,063 Underlying: Common Stock · 89,063 shares Expires 2031-04-19 F2 · derivative.exercise_date: Restricted options to purchase common stock. Options vest ratably at share prices of $3, $4, $5 and $7. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:03 UTC |
Silas James ASVP Research and Innovation
|
GrantCommon Stock | 118,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000075 · wf-form4_161905338659502.xml · nonDerivative · entry 1 Silas James A · CIK 0001771630 · SVP Research and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,012 F1 · shares: Restricted shares that vest ratably over four years from date of grant. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:02 UTC |
Allen Denise DanielleSVP & Chief of Staff
|
GrantStock Option · Derivative | 93,750 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000074 · wf-form4_161905333676611.xml · derivative · entry 3 Allen Denise Danielle · CIK 0001812801 · SVP & Chief of Staff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Shares · 93,750 shares Expires 2031-04-19 F3 · derivative.exercise_date: Restricted options to purchase common stock. Options vest based on percentage of revenue from new products developed over a three-year period. Vesting is ratable at revenue percentages of 15%, 20% and 25%, and is determined on 12/31/24. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:02 UTC |
Allen Denise DanielleSVP & Chief of Staff
|
GrantStock Option · Derivative | 93,750 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0000928054-21-000074 · wf-form4_161905333676611.xml · derivative · entry 2 Allen Denise Danielle · CIK 0001812801 · SVP & Chief of Staff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Shares · 93,750 shares Expires 2031-04-19 F2 · derivative.exercise_date: Restricted options to purchase common stock. Options vest ratably at share prices of $3, $4, $5 and $7. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 01:02 UTC |
Allen Denise DanielleSVP & Chief of Staff
|
GrantCommon Shares | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000074 · wf-form4_161905333676611.xml · nonDerivative · entry 1 Allen Denise Danielle · CIK 0001812801 · SVP & Chief of Staff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,307 F1 · shares: Restricted shares that vest ratably over four years from date of grant. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 01:43 UTC |
Ezell Ryan GillisPresident, Chem. Technologies
|
Tax withholdingCommon Shares | 6,764 | $1.75 | $11,837.00 |
DisclosureSEC source: 0000928054-21-000061 · wf-form4_161775964993805.xml · nonDerivative · entry 1 Ezell Ryan Gillis · CIK 0001805598 · President, Chem. Technologies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,377 Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 01:38 UTC |
Bigney Nicholas J.SVP General Counsel
|
Tax withholdingCommon Stock | 5,544 | $1.75 | $9,702.00 |
DisclosureSEC source: 0000928054-21-000059 · wf-form4_161775936357331.xml · nonDerivative · entry 1 Bigney Nicholas J. · CIK 0001801480 · SVP General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,894 Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 01:34 UTC |
Silas James ASVP Research and Innovation
|
Tax withholdingCommon Stock | 6,323 | $1.75 | $11,065.25 |
DisclosureSEC source: 0000928054-21-000057 · wf-form4_161775906753039.xml · nonDerivative · entry 1 Silas James A · CIK 0001771630 · SVP Research and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,262 Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 00:54 UTC |
GIBSON JOHN W JRDirector · CEO and President
|
Tax withholdingCommon Shares | 23,833 | $1.75 | $41,707.75 |
DisclosureSEC source: 0000928054-21-000055 · wf-form4_161775673359850.xml · nonDerivative · entry 1 GIBSON JOHN W JR · CIK 0001189981 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 838,760 Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 00:44 UTC |
Allen Denise DanielleSVP & Chief of Staff
|
Tax withholdingCommon Shares | 6,709 | $1.75 | $11,740.75 |
DisclosureSEC source: 0000928054-21-000052 · wf-form4_161775608365246.xml · nonDerivative · entry 1 Allen Denise Danielle · CIK 0001812801 · SVP & Chief of Staff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,307 Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 23:52 UTC |
Silas James ASVP Research and Innovation
|
GrantCommon Stock | 17,506 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000028 · wf-form4_161542033594806.xml · nonDerivative · entry 1 Silas James A · CIK 0001771630 · SVP Research and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,585 F1 · shares: Granted as a portion of 2020 management incentive plan. Share number calculated based on the closing price on date of grant. Vests six months from date of grant. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 23:49 UTC |
Koid TengBengPresident Global Business Exec
|
GrantCommon Shares | 16,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000026 · wf-form4_161542015905190.xml · nonDerivative · entry 1 Koid TengBeng · CIK 0001413765 · President Global Business Exec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,869 F1 · shares: Granted as a portion of 2020 management incentive plan. Share number calculated based on the closing price on date of grant. Vests six months from date of grant. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 23:47 UTC |
Ezell Ryan GillisPresident, Chem. Technologies
|
GrantCommon Shares | 20,465 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000024 · wf-form4_161542002613977.xml · nonDerivative · entry 1 Ezell Ryan Gillis · CIK 0001805598 · President, Chem. Technologies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,141 F1 · shares: Granted as a portion of 2020 management incentive plan. Share number calculated based on the closing price on date of grant. Vests six months from date of grant. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 23:44 UTC |
Borton Michael E.Chief Financial Officer
|
GrantCommon Shares | 10,841 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000022 · wf-form4_161541987253200.xml · nonDerivative · entry 1 Borton Michael E. · CIK 0001817633 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,841 F1 · shares: Granted as a portion of 2020 management incentive plan. Share number calculated based on the closing price on date of grant. Vests six months from date of grant. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 23:40 UTC |
Bigney Nicholas J.SVP General Counsel
|
GrantCommon Stock | 15,763 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000020 · wf-form4_161541961884131.xml · nonDerivative · entry 1 Bigney Nicholas J. · CIK 0001801480 · SVP General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,438 F1 · shares: Granted as a portion of 2020 management incentive plan. Share number calculated based on the closing price on date of grant. Vests six months from date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.